FDA Seeks To Dominate In Federal/State Conflicts – Troy
This article was originally published in The Tan Sheet
Executive Summary
FDA is working to ensure that states do not create requirements that conflict with agency regulations, FDA Chief Counsel Daniel Troy stressed in remarks delivered at the Food & Drug Law Institute's annual conference
You may also be interested in...
FDA Final Rules Require Content Of Calcium, Other Compounds On OTC Labels
Content and warning label changes for calcium, magnesium, potassium and sodium dosages in orally ingested OTCs must be complied with by September 2005, according to two final rules published in the Federal Register March 24
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands